Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | -0.59% | -1.17% | -24.89% |
21/03 | Stifel Cuts Price Target on Vor Biopharma to $12 From $15, Maintains Buy Rating | MT |
21/03 | Oppenheimer Cuts Vor Biopharma Price Target to $15 From $18, Maintains Outperform Rating | MT |
Sales 2024 * | - | Sales 2025 * | 1.43M 119M | Capitalization | 115M 9.61B |
---|---|---|---|---|---|
Net income 2024 * | -102M -8.5B | Net income 2025 * | -115M -9.59B | EV / Sales 2024 * | - |
Net Debt 2024 * | 16.29M 1.36B | Net cash position 2025 * | 52.11M 4.34B | EV / Sales 2025 * | 44.2 x |
P/E ratio 2024 * |
-1.22
x | P/E ratio 2025 * |
-1.25
x | Employees | 168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.83% |
1 day | -0.59% | ||
1 week | -1.17% | ||
Current month | -28.69% | ||
1 month | -28.69% | ||
3 months | -27.78% | ||
6 months | -19.52% | ||
Current year | -24.89% |
Managers | Title | Age | Since |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 07/19/07 |
Nathan Jorgensen
DFI | Director of Finance/CFO | 47 | 01/20/01 |
Chief Tech/Sci/R&D Officer | 51 | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 30/20/30 |
Matt Patterson
CHM | Chairman | 52 | 20/20/20 |
Bob Ang
CEO | Chief Executive Officer | 49 | 07/19/07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.69 | -0.59% | 154,391 |
25/24/25 | 1.7 | -2.30% | 181,018 |
24/24/24 | 1.74 | -7.45% | 287,032 |
23/24/23 | 1.88 | +3.30% | 209,685 |
22/24/22 | 1.82 | +6.43% | 232,177 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.89% | 115M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VOR Stock